Potential biomarkers of haemophilic arthropathy : correlations with compatible additive magnetic resonance imaging scores
(2016) In Haemophilia 22(5). p.760-764- Abstract
Introduction: Although biomarkers are useful diagnostic tools to assess joint damage in osteoarthritis and rheumatoid arthritis, few data exist for biomarkers of haemophilic arthropathy. Aim: To evaluate the association between biomarkers and compatible additive magnetic resonance imaging (MRI) scores in patients with severe haemophilia A. Methods: Patients aged 12–35 years with no history of factor VIII (FVIII) inhibitors were enrolled in a controlled, cross-sectional, multinational investigation. Patients received primary or secondary prophylaxis or on-demand treatment with FVIII and underwent MRI on four joints (two ankles, two knees). Soluble biomarkers of cartilage and bone degradation, inflammation, and angiogenesis were assessed... (More)
Introduction: Although biomarkers are useful diagnostic tools to assess joint damage in osteoarthritis and rheumatoid arthritis, few data exist for biomarkers of haemophilic arthropathy. Aim: To evaluate the association between biomarkers and compatible additive magnetic resonance imaging (MRI) scores in patients with severe haemophilia A. Methods: Patients aged 12–35 years with no history of factor VIII (FVIII) inhibitors were enrolled in a controlled, cross-sectional, multinational investigation. Patients received primary or secondary prophylaxis or on-demand treatment with FVIII and underwent MRI on four joints (two ankles, two knees). Soluble biomarkers of cartilage and bone degradation, inflammation, and angiogenesis were assessed (serum levels of C-terminal telopeptides of type I collagen [CTX-I], cartilage oligomeric matrix protein [COMP], chondroitin-sulphate aggrecan turnover 846 epitope [CS846], tissue inhibitor of metalloproteinase 1 [TIMP-1]; plasma levels of vascular endothelial growth factor [VEGF], matrix metalloproteinases 3 and 9 [MMP3, MMP9]). Relationships between biomarkers and MRI scores were evaluated using Spearman rank correlation. Results: Biomarkers were assessed in 117 of 118 per-protocol patients. Mean and median CTX-I, COMP, TIMP-1, MMP3, MMP9, and VEGF values were within normal ranges (reference range not available for CS846 in healthy volunteers). No correlations between biomarkers and MRI scores were found, with the exception of CS846, which showed significant correlation in a subgroup of 22 on-demand patients (r = 0.436; P = 0.04). Conclusions: Compatible additive MRI scores showed no clear correlations with any of the potential biomarkers for haemophilic arthropathy in the overall population. CS846 levels were significantly correlated with MRI scores in patients treated on demand.
(Less)
- author
- Oldenburg, J. ; Zimmermann, R. ; Katsarou, O. ; Zanon, E. ; Kellermann, E. ; Lundin, B. LU and Ellinghaus, P.
- organization
- publishing date
- 2016-09-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- arthropathy, biological markers, haemophilia A, joints, magnetic resonance imaging
- in
- Haemophilia
- volume
- 22
- issue
- 5
- pages
- 5 pages
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:84990242359
- pmid:27339406
- wos:000387390000048
- ISSN
- 1351-8216
- DOI
- 10.1111/hae.12936
- language
- English
- LU publication?
- yes
- id
- 8e1e2ed8-29bc-402f-aa7a-1c59cb3ad29b
- date added to LUP
- 2016-12-13 11:54:46
- date last changed
- 2024-04-19 15:08:09
@article{8e1e2ed8-29bc-402f-aa7a-1c59cb3ad29b,
abstract = {{<p>Introduction: Although biomarkers are useful diagnostic tools to assess joint damage in osteoarthritis and rheumatoid arthritis, few data exist for biomarkers of haemophilic arthropathy. Aim: To evaluate the association between biomarkers and compatible additive magnetic resonance imaging (MRI) scores in patients with severe haemophilia A. Methods: Patients aged 12–35 years with no history of factor VIII (FVIII) inhibitors were enrolled in a controlled, cross-sectional, multinational investigation. Patients received primary or secondary prophylaxis or on-demand treatment with FVIII and underwent MRI on four joints (two ankles, two knees). Soluble biomarkers of cartilage and bone degradation, inflammation, and angiogenesis were assessed (serum levels of C-terminal telopeptides of type I collagen [CTX-I], cartilage oligomeric matrix protein [COMP], chondroitin-sulphate aggrecan turnover 846 epitope [CS846], tissue inhibitor of metalloproteinase 1 [TIMP-1]; plasma levels of vascular endothelial growth factor [VEGF], matrix metalloproteinases 3 and 9 [MMP3, MMP9]). Relationships between biomarkers and MRI scores were evaluated using Spearman rank correlation. Results: Biomarkers were assessed in 117 of 118 per-protocol patients. Mean and median CTX-I, COMP, TIMP-1, MMP3, MMP9, and VEGF values were within normal ranges (reference range not available for CS846 in healthy volunteers). No correlations between biomarkers and MRI scores were found, with the exception of CS846, which showed significant correlation in a subgroup of 22 on-demand patients (r = 0.436; P = 0.04). Conclusions: Compatible additive MRI scores showed no clear correlations with any of the potential biomarkers for haemophilic arthropathy in the overall population. CS846 levels were significantly correlated with MRI scores in patients treated on demand.</p>}},
author = {{Oldenburg, J. and Zimmermann, R. and Katsarou, O. and Zanon, E. and Kellermann, E. and Lundin, B. and Ellinghaus, P.}},
issn = {{1351-8216}},
keywords = {{arthropathy; biological markers; haemophilia A; joints; magnetic resonance imaging}},
language = {{eng}},
month = {{09}},
number = {{5}},
pages = {{760--764}},
publisher = {{Wiley-Blackwell}},
series = {{Haemophilia}},
title = {{Potential biomarkers of haemophilic arthropathy : correlations with compatible additive magnetic resonance imaging scores}},
url = {{http://dx.doi.org/10.1111/hae.12936}},
doi = {{10.1111/hae.12936}},
volume = {{22}},
year = {{2016}},
}